Jupiter Neurosciences, Inc. Common Stock
JUNSJupiter Neurosciences, Inc. (JUNS) is a biopharmaceutical company focused on developing treatments for neurological and psychiatric disorders. The company specializes in advancing innovative therapies targeting unmet medical needs in the field of brain health.
$1.21 +0.03 (2.54%)
Company News
Jupiter Neurosciences Highlights Critical Advancement of JOTROLâ„¢ Over Traditional Resveratrol with Breakthrough Bioavailability and CNS-Targeted Science
Jupiter Neurosciences announced a significant advancement in resveratrol technology with JOTROLâ„¢, achieving nine-fold increased bioavailability and reduced gastrointestinal side effects, with potential applications in neurodegenerative disease treatment and consumer supplements.
